Clinical Trial Update: Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for pyrotinib maleate tablets in combination with albumin paclitaxel and trastuzumab in HER2-positive breast cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Pyrotinib (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: West China Hospital | Conditions: Breast Cancer, HER2 Positive | Phase 1, Phase 2 | Status: UNKNOWN